We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of General Psychiatry |

This Month in Archives of General Psychiatry FREE

Arch Gen Psychiatry. 2007;64(6):629. doi:10.1001/archpsyc.64.6.629.
Text Size: A A A
Published online

Keefe et al60087 report the effects of antipsychotic treatment on neurocognition in 817 patients with schizophrenia from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) treatment study. After 2 months of double-blind, randomized treatment with olanzapine, perphenazine, quetiapine fumarate, risperidone, or ziprasidone hydrochloride, neurocognitive improvements were significant but small, with no significant differences among groups.

Moffitt et al60088 describe the relationship between major depressive disorder (MDD) and generalized anxiety disorder (GAD) as it unfolds in a birth cohort of 1000 individuals diagnosed on repeated prospective occasions. Comorbid GAD + MDD affected one tenth of participants, suggesting that GAD + MDD constitutes a greater health burden than estimated by retrospective surveys. Contrary to the prevailing notion that generalized anxiety onset occurs before depression, the reverse sequence occurred almost as often.

Clark et al60089 used data from a large British prospective cohort study to examine associations between childhood and adulthood psychological ill health and midlife affective and anxiety disorders. Childhood psychological ill health was independently associated with a one-fifth– to 2-fold increase in risk, while adulthood psychological ill health was associated with a 2- to 7-fold increase in risk. Early adulthood associations were significantly stronger for men.

Cooper-Kazaz et al60092 investigated the antidepressant effect of liothyronine sodium in euthyroid patients with major depressive disorder treated with sertraline hydrochloride. In the context of a randomized, double-blind, placebo-controlled trial, addition of liothyronine from the outset of treatment significantly increased both response and remission rates without increasing adverse effects.

Perlis et al60097 examined the emergence of suicidal thoughts and behaviors following citalopram hydrobromide treatment in a large cohort of patients participating in the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study of major depressive disorder. They identified an association between single nucleotide polymorphisms in the CREB1 gene, whose product has been previously implicated in major depressive disorder, suicide, and antidepressant response, and the emergence of suicidality among men.

Wang et al60093 examined whether instructions to attend to social cues when interpreting communicative intent would normalize brain activity in children with autism spectrum disorders. When instructed simply to pay attention, children with autism spectrum disorders showed no significant activity in the medial prefrontal cortex, a region typically involved in understanding others' mental states. In contrast, normative medial prefrontal cortex activity was observed when attention was explicitly directed toward the speaker's facial expression and tone of voice.

Wassink et al60094 examined whether the serotonin transporter promoter polymorphism 5-HTTLPR influenced brain structure volumes in young male children with autism. They found that the short allele was additively associated with increasing cerebral cortical gray matter volumes in 2 independent samples of such children. These results thus establish a link between a genetic variant and a biological trait that had both been previously associated with autism.

Zhong et al60098 measured β-site amyloid precursor protein–cleaving enzyme 1 (BACE1) activity in cerebrospinal fluid (CSF) and found that patients with mild cognitive impairment (MCI) showed increased CSF BACE1 activity. Moreover, they also found that increased CSF levels of BACE1 in patients with MCI were associated with an increased risk ratio for MCI.

Schilt et al60083 conducted prospective neuropsychological tests before and after first Ecstasy use. The findings suggest that even a low cumulative dose of Ecstasy negatively affects verbal memory performance.

Schiltz et al60091 examined with magnetic resonance imaging whether pedophilic offenders show structural neuronal alterations in brain regions that are critical for sexual behavior. They found a reduced volume of the right amygdala as well as reduced gray matter in closely related brain structures, predicting how focused sexual offenses were on uniform pedophilic activity.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.